Triple-Combination Control for Type 2 Diabetes
Trijardy XR 25mg/5mg/1000mg is a once-daily, extended-release tablet that combines three powerful blood sugar-lowering medications into one convenient dose. It is specifically formulated for adults with type 2 diabetes to help improve glycemic control alongside diet and exercise.
How Trijardy XR Works
This medication uses three distinct mechanisms to manage your blood sugar levels:
- Empagliflozin (25mg): Helps your kidneys remove sugar from your bloodstream through your urine. It also provides significant cardiovascular benefits.
- Linagliptin (5mg): Increases the levels of natural substances that lower blood sugar when it is high.
- Metformin HCl (1000mg): Decreases the amount of sugar your liver makes and helps your body respond better to the insulin it naturally produces.
Benefits of Trijardy XR
- Simplified Regimen: Replaces multiple pills with a single daily tablet, making it easier to stay on track with your treatment.
- Cardiovascular Protection: Clinically proven to reduce the risk of cardiovascular death in adults with type 2 diabetes and established cardiovascular disease.
- Extended Release: The XR formulation provides a steady release of medication throughout the day, often resulting in fewer stomach-related side effects compared to immediate-release metformin.
Usage Instructions
For the best results and to minimize stomach upset, take Trijardy XR once daily in the morning with a meal. Swallow the tablet whole; do not crush, chew, or break it, as this can interfere with the extended-release mechanism.
If you have questions about your dosage or how this medication interacts with your current health plan, you can contact a GoMed pharmacist for professional guidance.
Important Safety Information
Trijardy XR is a prescription medication. It is not for treating type 1 diabetes or diabetic ketoacidosis. Before starting, inform your doctor if you have kidney problems, as your renal function (eGFR) must be assessed. Avoid excessive alcohol consumption while taking this medication to reduce the risk of lactic acidosis.